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Tumors that exhibit dual differentiation; for example, showing both mucus production and dense core granules within the cytoplasm of the same cell, are extremely rare even among composite-type tumors [10] . A very few cases of such tumors involving the stomach have been reported previously, although the peculiar biological behavior has not been described in detail [7, 11] .
Here, we describe a rare case of a tumor, with lymph node metastasis, showing dual differentiation composed of PDECC of the stomach containing differentiated signet ring cells, which had a poor prognosis with aggressive tumor progression.
Case report
A 70-year-old woman was referred to hospital with a positive fecal occult blood test. Endoscopic examination revealed an ulcerated lesion located in the middle third of the stomach, which was diagnosed as a histologically benign ulcer. The patient was followed on an outpatient basis and on the third endoscopic examination, a gastric adenocarcinoma was confi rmed by biopsy. Computed tomography (CT) and ultrasonography showed a lymph node measuring 10 mm in diameter on the lesser curve of the stomach that was suggestive of metastasis, but no metastases at distant sites including the liver were identifi ed. Laboratory tumor markers were slightly elevated, with a carcinoembryonic antigen (CEA) level of 8.0 ng/ ml (normal range [NR] < 5.0 ng/ml) and carbohydrate [1] [2] [3] . Poorly differentiated endocrine cell carcinoma (PDECC), which is a rare and unpredictable tumor, occasionally shows multidirectional differentiation with adenocarcinoma and/or squamous cell prolif-antigen 19-9 (CA19-9) of 52 U/ml (NR < 37 U/ml). Twelve months after the initial diagnosis, the patient underwent a distal gastrectomy with lymph node dissection. The postoperative course was uneventful and the patient was discharged 11 days after the surgery.
CT examination performed 6 months after the surgery revealed lymph node recurrence of the tumor around the abdominal aorta. TS-1 chemotherapy achieved a partial response at 8 months after the surgery, but the patient died of lymph node metastases and peritoneal dissemination 16 months after the surgical treatment.
Methods
Tissue specimens were fi xed in 4% formaldehyde and processed to paraffi n-embedded sections. The slides, stained with hematoxylin and eosin (H & E) and alcian blue-periodic acid-Schiff (AB-PAS), were evaluated by the Grimelius method. Labeled streptavidin biotin (LSAB) immunohistochemistry was performed on 3-μm tissue sections using an i6000 automated staining system (BioGenex, San Ramon, CA, USA). Representative slides were deparaffi nized and stained using the following antibodies: chromogranin A (Dako Japan, Kyoto, Japan; polyclonal, diluted 1: 500), synaptophysin (Dako; polyclonal, diluted 1: 100), MUC2 (Ccp58; Novocastra Laboratories, Newcastle, UK; monoclonal, diluted 1: 200), and Cdx2 (CDX2-88; BioGenex; monoclonal, diluted 1: 200). For negative controls, similar dilutions of control mouse IgG1 were substituted for the antibody.
Pathological fi ndings
Histological examination of the resected specimen revealed a large ulcerated tumor, measuring 3.7 × 3.5 cm, located in the distal stomach, with serosal invasion and lymphatic and neural involvement. Metastases were also found in the second-tier lymph nodes (nodes according to the Japanese classifi cation of gastric carcinoma) [12] .
H & E staining showed a tumor histologically comprised of two components: (i) an endocrine cell carcinoma containing poorly differentiated cells with diffuse granular cytoplasm arranged in cord-like structures and (ii) a signet ring cell component forming mucinous lakes (Fig. 1 A, B, C ). There were also transitional areas between the two different types of tumor cells.
Immunohistochemical examination showed that both the endocrine cell carcinoma cells and signet ring tumor cells were diffusely positive for chromogranin A and synaptophysin (Fig. 2 A, B) . Mucin within the cytoplasm of goblet cells was positive for MUC2.
Discussion
Extrapulmonary malignant neoplasms composed largely or entirely of small neoplastic cells with a markedly hyperchromatic nucleus and scanty cytoplasm have been described as small cell carcinoma [4, 7, 9] , neuroendocrine carcinoma [13, 14] , anaplastic carcinoma [15] , or small cell epidermoid carcinoma [16] . Unlike lung cancer, extrapulmonary neoplasms of this type are uncommon but have been reported in a variety of other organs [4, 7-9, 13, 15] . Although PDECCs of the stomach are extremely rare, we want to emphasize the importance of recognizing this tumor as a specifi c type of cancer. PDECCs have distinct phenotypic activity characterized by early invasion and metastases, and are frequently associated with paraendocrine syndromes [7] [8] [9] . In our patient, the case of PDECC of the stomach was characterized by an aggressive clinical course, with a poor prognosis involving paraaortic lymph node metastases 6 months after surgery, resulting in death 10 months after the relapse, despite chemotherapy.
PDECC of the stomach is classifi ed as either a puretype tumor or a composite-type tumor with an admixture of adenocarcinomatous cells and/or differentiated squamous cells [7] . Most cases of the composite-type of PDECC have a well-differentiated adenocarcinomatous component in the mucosal layer. Only one case of a composite-type PDECC tumor with dual differentiation of an adenomatous component positive for chromogranin has been reported previously. That report described a PDECC with signet ring cell differentiation, and both cell types were immunohistochemically positive for chromogranin and synaptophysin, as in the case we have described here. PDECC of the stomach associated with poorly differentiated adenocarcinoma would be a signifi cant fi nding in the analysis of PDECC progression, but unfortunately this previously reported case was not described in detail.
Composite epithelial tumors can be classifi ed according to the Armed Forces Institute of Pathology (AFIP) criteria [10] in the stomach; this had only one component with a combination of well-differentiated adenocarcinoma and carcinoid [11] . Amphicrine tumors described by the AFIP criteria showed two types of intracytoplasmic granules, including small electron-dense granules and large lucent mucin droplets, on electron microscopy. The present case is important for pathologists assessing PDECCs for the presence of neuroendocrine differentiation, particularly for tumors that do not display characteristic argyrophilia or ultrastructural neurosecretory granules. The recognition of these types of tumors of the stomach is imperative in view of their aggressive biological behavior with an associated poor prognosis irrespective of treatment modalities. Therefore, both histochemical and immunohistochemical evaluation of the tumor is necessary for the pathological diagnosis of a gastric endocrine tumor. Goblet cell carcinoid, which is a distinctive appendiceal neoplasm exhibiting both neuroendocrine and glandular differentiation, has been reported to display Of these six types of tumors, the amphicrine tumors are extremely rare and only one case has been described a spectrum of histological features and to possess the potential to transform to an adenocarcinoma phenotype of either signet ring cell or poorly differentiated adenocarcinoma type as a subclassifi cation of tumors [17] . Tang et al. [17] also reported that their clinical outcome could be differentiated by subclassifi cation of tumors, and the survival of goblet cell carcinoid of poorly differentiated adenocarcinoma type was dismal. Also, neoplastic cells of signet ring cell carcinoma in gastric cancer sometimes show endocrine cell differentiation [18] . Bakkelund et al. [18] reported that signet ring cell carcinomas could be of neuroendocrine origin, and they proposed, from their immunohistochemical investigation of signet ring cells in gastric carcinomas, that signet ring cell carcinomas develop by gradual differentiation from enterochromaffi n-like cells, via signet ring cells with neuroendocrine immunoreactivity, toward signet ring cells. We suggest that, from its unique pathological features and clinical behavior, the present case might be a subtype of signet ring cell carcinoma with neuroendocrine immunoreactivity.
